Skip to main content
Clinical Trials/NCT03187392
NCT03187392UnknownPhase 3

Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Insertion of Subcutaneous Birth Control Implants : A Randomized Controlled Trial

Assiut University1 site in 1 country144 target enrollmentStarted: June 12, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Enrollment
144
Locations
1
Primary Endpoint
Mean pain score during insertion of implant

Study Overview

Brief Summary

The aim of our study is to compare the analgesic effect of topical application of lidocaine-prilocaine cream and lidocaine infiltration during insertion of birth control implants

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • female want use subcutaneous birth control

Exclusion Criteria

  • previous scar at side of insertion

Arms & Interventions

lidocaine injection

Active Comparator

Intervention: Lidocaine Injectable Product (Drug)

lidocaine-prilocaine cream

Experimental

Intervention: Lidocaine Topical Cream [LMX] (Drug)

Outcomes

Primary Outcomes

Mean pain score during insertion of implant

Time Frame: 10 minutes

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Armia Michael

resident physician

Assiut University

Study Sites (1)

Loading locations...

Similar Trials